www.fdanews.com/articles/152558-vestiq-pharmaceuticals-acquires-ndas-for-oravig-and-zuplenz-oral-soluble-film
Vestiq Pharmaceuticals Acquires NDAs for Oravig and Zuplenz Oral Soluble Film
January 21, 2013
Vestiq Pharmaceuticals, an emerging specialty pharmaceutical company, formally announces its launch of products that began commercialization in December of 2012.
MarketWire
MarketWire